Health & Life Co (ROCO:1781) Research & Development: NT$19.9 Mil (TTM As of Dec. 2025)


ROCO:1781 Health & Life Co Ltd ROCO:1781
49 GF Score
Price NT$11.85
GF Value NT$8.77
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Health & Life Co Research & Development?

Health & Life Co ROCO:1781 +0.42% 49 Research & Development is NT$19.9 Mil as of Dec. 2025. GuruFocus rates ROCO:1781 with a GF Score™ of 49/100 and a GF Value™ of NT$8.77 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Health & Life Co's Research & Development for the three months ended in Dec. 2025 was NT$5.1 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$19.9 Mil.

Health & Life Co  (ROCO:1781) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Health & Life Co Research & Development Related Terms

Health & Life Co Research & Development Historical Data

* Premium members only.

The historical data trend for Health & Life Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health & Life Co Research & Development Chart

Health & Life Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.81 17.34 16.16 18.35 19.94

Health & Life Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.40 4.23 5.42 5.14 5.15
ROCO:1781
49GF Score
Health & Life Co Ltd ROCO:1781
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health & Life Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$19.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$19.9 Mil mean?
Health & Life Co (ROCO:1781) has a Research & Development of NT$19.9 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Health & Life Co and its competitors.
Is Health & Life Co's Research & Development too high?
Health & Life Co's current Research & Development is NT$19.9 Mil. Overall, Health & Life Co has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Health & Life Co's Research & Development compare to ABT and SYK?
Health & Life Co's Research & Development of NT$19.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Health & Life Co and its competitors. Health & Life Co's current Research & Development is NT$19.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health & Life Co stock overvalued right now?
Based on GuruFocus' analysis, Health & Life Co (ROCO:1781) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$8.77, compared to a current price of NT$11.85 — trading 35.1% above its estimated fair value. The current Research & Development is NT$19.9 Mil. Health & Life Co's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Health & Life Co (ROCO:1781), the current Research & Development is NT$19.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health & Life Co (ROCO:1781) Overvalued in 2026?

Based on GuruFocus' analysis, Health & Life Co stock appears to be overvalued. The current stock price of NT$11.85 is trading 35.1% above its estimated GF Value™ of NT$8.77. GuruFocus considers Health & Life Co to be Significantly Overvalued.

Key valuation signals for ROCO:1781:

  • Research & Development: NT$19.9 Mil
  • GF Value™: NT$8.77 vs. price of NT$11.85 (35.1% above fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the ROCO:1781 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Health & Life Co Business Description

Address Jian 1st Road, 9th Floor, No-186, New Taipei City, TWN
Health & Life Co Ltd manufactures medical devices in the fields of cardiovascular disease and in-vitro diagnostics in Taiwan. Its product portfolio includes blood pressure monitor series, nebulizer, and blood glucose monitoring system, blood glucose stripes and Thermometer.
49GF Score

Get the complete analysis for ROCO:1781

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$11.85
Price
NT$8.77
GF Value